Baudax BioInc Valuation
| BXRX Stock | USD 0.01 0.0006 5.66% |
Baudax BioInc seems to be undervalued based on Macroaxis valuation methodology. Our model approximates the value of Baudax BioInc from analyzing the firm fundamentals such as Operating Margin of (27.60) %, shares outstanding of 43.59 M, and Return On Equity of -47.04 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting Baudax BioInc's valuation include:
Price Book 0.6815 | Enterprise Value 17.7 M | Enterprise Value Ebitda (0.26) | Price Sales 0.7489 | Enterprise Value Revenue 6.6339 |
Undervalued
Today
Please note that Baudax BioInc's price fluctuation is very risky at this time. Calculation of the real value of Baudax BioInc is based on 3 months time horizon. Increasing Baudax BioInc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Baudax BioInc is useful when determining the fair value of the Baudax stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Baudax BioInc. Since Baudax BioInc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Baudax Stock. However, Baudax BioInc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0112 | Real 6.01 | Target 24.0 | Hype 0.01 | Naive 0.008986 |
The real value of Baudax Stock, also known as its intrinsic value, is the underlying worth of Baudax BioInc Company, which is reflected in its stock price. It is based on Baudax BioInc's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Baudax BioInc's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Baudax BioInc's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Baudax BioInc helps investors to forecast how Baudax stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Baudax BioInc more accurately as focusing exclusively on Baudax BioInc's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Baudax BioInc's intrinsic value based on its ongoing forecasts of Baudax BioInc's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Baudax BioInc's closest peers. When choosing an evaluation method for Baudax BioInc, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Baudax BioInc Investments |
|
Baudax Valuation Trend
Knowing Baudax BioInc's actual value is paramount for traders to make sound investment determinations. Baudax BioInc's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Baudax BioInc's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Baudax BioInc's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Baudax Market Cap
Baudax BioInc is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 197.45 Million. Baudax BioInc adds roughly 950,329 in market capitalization claiming only tiny portion of equities under Health Care industry.Baudax BioInc Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Baudax BioInc's current stock value. Our valuation model uses many indicators to compare Baudax BioInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Baudax BioInc competition to find correlations between indicators driving Baudax BioInc's intrinsic value. More Info.Baudax BioInc is rated third in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about 22.72 of Price To Book per Price To Earning. Price To Book Ratio is likely to drop to -0.04 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Baudax BioInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Baudax BioInc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Baudax BioInc's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Baudax BioInc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Baudax BioInc and how it compares across the competition.
About Baudax BioInc Valuation
The stock valuation mechanism determines the current worth of Baudax BioInc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Baudax BioInc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Baudax BioInc based exclusively on its fundamental and basic technical indicators. By analyzing Baudax BioInc's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Baudax BioInc's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Baudax BioInc. We calculate exposure to Baudax BioInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Baudax BioInc's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -5.2 M | -4.9 M | |
| Pretax Profit Margin | (41.70) | (43.78) | |
| Operating Profit Margin | (40.29) | (42.31) | |
| Net Loss | (41.70) | (43.78) | |
| Gross Profit Margin | (5.20) | (5.46) |
8 Steps to conduct Baudax BioInc's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Baudax BioInc's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Baudax BioInc's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Baudax BioInc's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Baudax BioInc's revenue streams: Identify Baudax BioInc's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Baudax BioInc's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Baudax BioInc's growth potential: Evaluate Baudax BioInc's management, business model, and growth potential.
- Determine Baudax BioInc's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Baudax BioInc's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Baudax BioInc Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Baudax BioInc does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 331.6 K |
Baudax BioInc Current Valuation Indicators
Valuation refers to the process of determining the present value of Baudax BioInc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Baudax we look at many different elements of the entity such as Baudax's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Baudax BioInc's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Baudax BioInc's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Baudax BioInc, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Baudax BioInc's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Baudax BioInc's worth.When determining whether Baudax BioInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Baudax BioInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Baudax Bioinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Baudax Bioinc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Baudax Stock analysis
When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.13) | Revenue Per Share 0.318 | Quarterly Revenue Growth (0.23) | Return On Assets (1.15) | Return On Equity (47.04) |
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.